The U.S. Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) announced the lifting of the recommended pause on the use of the Johnson & Johnson COVID-19 vaccine.
Both agencies recommended the hiatus on April 13, after learning of six cases of a rare blood clotting syndrome among women who recently received the vaccine.